Savant Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
25,842
+3,637
| +16% | +$284K | 0.01% | 565 |
|
|
2025
Q1 | $1.61M | Buy |
22,205
+11,210
| +102% | +$813K | 0.01% | 580 |
|
|
2024
Q4 | $814K | Sell |
10,995
-4,542
| -29% | -$336K | 0.01% | 722 |
|
|
2024
Q3 | $1.03M | Sell |
15,537
-11,728
| -43% | -$774K | 0.01% | 636 |
|
|
2024
Q2 | $2.52M | Sell |
27,265
-361
| -1% | -$33.3K | 0.03% | 319 |
|
|
2024
Q1 | $2.64M | Buy |
27,626
+17,903
| +184% | +$1.71M | 0.03% | 284 |
|
|
2023
Q4 | $741K | Sell |
9,723
-472
| -5% | -$36K | 0.01% | 478 |
|
|
2023
Q3 | $706K | Sell |
10,195
-151
| -1% | -$10.5K | 0.01% | 463 |
|
|
2023
Q2 | $976K | Buy |
10,346
+160
| +2% | +$15.1K | 0.02% | 385 |
|
|
2023
Q1 | $843K | Sell |
10,186
-175
| -2% | -$14.5K | 0.02% | 362 |
|
|
2022
Q4 | $773K | Sell |
10,361
-26
| -0.3% | -$1.94K | 0.02% | 301 |
|
|
2022
Q3 | $858K | Sell |
10,387
-606
| -6% | -$50.1K | 0.03% | 250 |
|
|
2022
Q2 | $1.05M | Buy |
10,993
+127
| +1% | +$12.1K | 0.03% | 225 |
|
|
2022
Q1 | $1.28M | Buy |
10,866
+123
| +1% | +$14.5K | 0.04% | 210 |
|
|
2021
Q4 | $1.39M | Buy |
10,743
+3,303
| +44% | +$428K | 0.05% | 207 |
|
|
2021
Q3 | $842K | Buy |
7,440
+365
| +5% | +$41.3K | 0.03% | 236 |
|
|
2021
Q2 | $733K | Buy |
7,075
+76
| +1% | +$7.87K | 0.03% | 242 |
|
|
2021
Q1 | $585K | Sell |
6,999
-79
| -1% | -$6.6K | 0.03% | 259 |
|
|
2020
Q4 | $646K | Sell |
7,078
-615
| -8% | -$56.1K | 0.04% | 234 |
|
|
2020
Q3 | $614K | Buy |
7,693
+75
| +1% | +$5.99K | 0.04% | 226 |
|
|
2020
Q2 | $526K | Buy |
7,618
+742
| +11% | +$51.2K | 0.04% | 236 |
|
|
2020
Q1 | $432K | Buy |
6,876
+4,143
| +152% | +$260K | 0.04% | 244 |
|
|
2019
Q4 | $213K | Buy |
+2,733
| New | +$213K | 0.03% | 333 |
|